Warberg Asset Management LLC Virpax Pharmaceuticals, Inc. Transaction History

Warberg Asset Management LLC

  • $12.6 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
SELL
$0.62 - $12.0 $1,240 - $24,000
-2,000 Reduced 10.52%
17,012 $10,000
Q3 2022

Nov 07, 2022
SELL
$1.15 - $11.9 $561 - $5,807
-488 Reduced 2.5%
19,012 $23,000
Q2 2022

Aug 11, 2022
BUY
$1.22 - $2.25 $2,183 - $4,027
1,790 Added 10.11%
19,500 $33,000
Q1 2022

May 13, 2022
BUY
$1.86 - $3.61 $32,940 - $63,933
17,710 New
17,710 $39,000

About Virpax Pharmaceuticals, Inc.

VRPX Quotes by TradingView
  • Ticker VRPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,714,600
  • Market Cap $7.15M
  • Description
  • Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical no...
More about VRPX
Track This Portfolio

Track Warberg Asset Management LLC Portfolio

Follow Warberg Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Warberg Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Warberg Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email